Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 72

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer’s Disease

Lee, Kihwan, Kim, Hyunju, An, Kyongman, Kwon, Oh-Bin, Park, Sungjun, Cha, Jin Hee, Kim, Myoung-Hwan, Lee, Yoontae, Kim, Joung-Hun, Cho, Kwangwook, Kim, Hye-Sun · 2016 · Scientific Reports

Abstract

MicroRNAs have emerged as key factors in development, neurogenesis and synaptic functions in the central nervous system. In the present study, we investigated a pathophysiological significance of microRNA-188-5p (miR-188-5p) in Alzheimer’s disease (AD). We found that oligomeric Aβ 1-42 treatment diminished miR-188-5p expression in primary hippocampal neuron cultures and that miR-188-5p rescued the Aβ 1-42-mediated synapse elimination and synaptic dysfunctions. Moreover, the impairments in cognitive function and synaptic transmission observed in 7-month-old five familial AD (5XFAD) transgenic mice, were ameliorated via viral-mediated expression of miR-188-5p. miR-188-5p expression was down-regulated in the brain tissues from AD patients and 5XFAD mice. The addition of miR-188-5p rescued the reduction in dendritic spine density in the primary hippocampal neurons treated with oligomeric Aβ 1-42 and cultured from 5XFAD mice. The reduction in the frequency of mEPSCs was also restored by addition of miR-188-5p. The impairments in basal fEPSPs and cognition observed in 7-month-old 5XFAD mice were ameliorated via the viral-mediated expression of miR-188-5p in the hippocampus. Furthermore, we found that miR-188 expression is CREB-dependent. Taken together, our results suggest that dysregulation of miR-188-5p expression contributes to the pathogenesis of AD by inducing synaptic dysfunction and cognitive deficits associated with Aβ-mediated pathophysiology in the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep34433

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 46

  1. Davis, G. M., Haas, M. A. & Pocock, R. MicroRNAs: Not “Fine-Tuners” but Key Regulators of Neuronal Development and Function. Front. Neurol. 6, 245, doi: 10.3389/fneur.2015.00245 (2015). · DOI
  2. Ebert, M. S. & Sharp, P. A. Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515–524 (2012). · DOI · Paper page
  3. Cohen, J. E., Lee, P. R., Chen, S., Li, W. & Fields, R. D. MicroRNA regulation of homeostatic synaptic plasticity. Proc. Natl. Acad. Sci. USA 108, 11650–11655 (2011). · DOI · Paper page
  4. Yuste, R. & Bonhoeffer, T. Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu. Rev. Neurosci. 24, 1071–1089 (2001). · DOI · Paper page
  5. Lu, W. et al. Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29, 243–254 (2001). · DOI · Paper page
  6. Pogue, A. I., Hill, J. M. & Lukiw, W. J. MicroRNA (miRNA): Sequence and stability, viroid-like properties, and disease association in the CNS. Brain Res. 1584, 73–79 (2014). · DOI
  7. Saba, R. & Schratt, G. M. MicroRNAs in neuronal development, function and dysfunction. Brain Res. 1338, 3–13 (2010). · DOI
  8. Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572–580 (1991). · DOI · Paper page
  9. Jo, J. et al. Abeta(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3beta. Nat. Neurosci. 14, 545–547 (2011). · DOI · Paper page
  10. Trinchese, F. et al. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann. Neurol. 55, 801–814 (2004). · DOI · Paper page
  11. Walsh, D. M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo . Nature 416, 535–539 (2002). · DOI · Paper page
  12. Lee, K. et al. An activity-regulated microRNA, miR-188, controls dendritic plasticity and synaptic transmission by downregulating neuropilin-2. J. Neurosci. 32, 5678–5687 (2012). · DOI
  13. Bliss, T. V. & Collingridge, G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31–39 (1993). · DOI · Paper page
  14. Tran, T. S. et al. Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature 462, 1065–U1128 (2009). · DOI · Paper page
  15. Chen, H. et al. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 25, 43–56 (2000). · DOI · Paper page
  16. Kolodkin, A. L. et al. Neuropilin is a Semaphorin III receptor. Cell 90, 753–762 (1997). · DOI · Paper page
  17. Kruger, R. P., Aurandt, J. & Guan, K. L. Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 6, 789–800 (2005). · DOI · Paper page
  18. Shimakawa, S. et al. Neuropilin-2 is overexpressed in the rat brain after limbic seizures. Brain Res. 956, 67–73 (2002). · doi:10.1016/s0006-8993(02)03482-0
  19. Chen, C. et al. Roles of neuropilins in neuronal development, angiogenesis, and cancers. World J. Surg. 29, 271–275 (2005). · DOI
  20. Gu, C. et al. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J. Biol. Chem. 277, 18069–18076 (2002). · DOI · Paper page
  21. Arancibia, S. et al. Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiol. Dis. 31, 316–326 (2008). · DOI · Paper page
  22. Gu, Z., Liu, W. & Yan, Z. {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution. J. Biol. Chem. 284, 10639–10649 (2009). · DOI · Paper page
  23. Fumagalli, F., Racagni, G. & Riva, M. A. The expanding role of BDNF: a therapeutic target for Alzheimer’s disease? Pharmacogenomics J. 6, 8–15 (2006). · DOI · Paper page
  24. Li, W., Calfa, G., Larimore, J. & Pozzo-Miller, L. Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice. Proc. Natl. Acad. Sci. USA 109, 17087–17092 (2012). · DOI
  25. Ramser, E. M. et al. Amyloid-beta oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol. Biol. Cell 24, 2494–2505 (2013). · DOI
  26. Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H. & Burns, J. M. Is Alzheimer’s disease a systemic disease? Biochim. Biophys. Acta. ; 10.1016/j.bbadis.2014.04.012 (2014). · DOI · Paper page
  27. Ripoli, C. et al. Effects of different amyloid beta-protein analogues on synaptic function. Neurobiol. Aging 34, 1032–1044 (2013). · DOI
  28. Song, J. M. et al. A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer’s disease. Exp. Neurol. 252, 105–113 (2014). · DOI
  29. Fanselow, M. S. Contextual fear, gestalt memories, and the hippocampus. Behav. Brain Res. 110, 73–81 (2000). · DOI · Paper page
  30. Kimura, R. & Ohno, M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol. Dis. 33, 229–235 (2009). · DOI · Paper page
  31. Seo, J. et al. Activity-Dependent p25 Generation Regulates Synaptic Plasticity and Abeta-Induced Cognitive Impairment. Cell 157, 486–498 (2014). · DOI
  32. Bliss, T. V. & Lomo, T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232, 331–356 (1973). · DOI · Paper page
  33. Sala, C. & Segal, M. Dendritic spines: the locus of structural and functional plasticity. Physiol. Rev. 94, 141–188 (2014). · DOI · Paper page
  34. Zhang, J., Hu, M., Teng, Z. Q., Tang, Y. P. & Chen, C. Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer’s Disease. J. Neurosci. 34, 14919–14933 (2014). · DOI
  35. Wu, J. B. et al. MicroRNA-188 suppresses G(1)/S transition by targeting multiple cyclin/CDK complexes. Cell Commun. Signal 12, 66, doi: 10.1186/s12964-014-0066-6 (2014). · DOI
  36. Li, C. J. et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Invest. 125, 1509–1522 (2015). · DOI · Paper page
  37. Jung, H. J. & Suh, Y. MicroRNA in Aging: From Discovery to Biology. Curr. genomics 13, 548–557 (2012). · DOI
  38. Hebert, S. S. et al. MicroRNA regulation of Alzheimer’s Amyloid precursor protein expression. Neurobiol. Dis. 33, 422–428 (2009). · DOI · Paper page
  39. Schonrock, N., Matamales, M., Ittner, L. M. & Gotz, J. MicroRNA networks surrounding APP and amyloid-beta metabolism - Implications for Alzheimer’s disease. Exp. Neurol., 235, 447–454 (2011). · DOI
  40. Wang, W. X. et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 177, 334–345 (2010). · DOI · Paper page
  41. Banzhaf-Strathmann, J. et al. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer’s disease. EMBO J. 33, 1667–1680 (2014). · DOI · Paper page
  42. Kim, J. et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220–1224 (2007). · DOI · Paper page
  43. Martins, M. et al. Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson’s disease. PLoS one 6, e25443, doi: 10.1371/journal.pone.0025443 (2011). · DOI · Paper page
  44. Xiong, R. et al. MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration. Neurobiol. Aging 35, 705–714 (2014). · DOI
  45. An, K. et al. Exosomes neutralize synaptic-plasticity-disrupting activity of A beta assemblies in vivo . Mol. Brain 6, 47, doi: 10.1186/1756-6606-6-47 (2013). · DOI · Paper page
  46. Liu, S. J. & Lachamp, P. The activation of excitatory glutamate receptors evokes a long-lasting increase in the release of GABA from cerebellar stellate cells. J. Neurosci. 26, 9332–9339 (2006). · DOI

Cited by

See all 72

Metadata

Authors
Lee, K., Kim, H., An, K., Kwon, O.-B., Park, S., Cha, J. H., Kim, M.-H., Lee, Y., Kim, J.-H., Cho, K., & Kim, H.-S.
Venue
Scientific Reports
Published
2016-10-06
Volume
6
Issue
1
ISSN
2045-2322
Cited by
72
References
10
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer’s Disease. https://app.cochat.ai/papers/10.1038/srep34433
The paper
Lee, K., Kim, H., An, K., Kwon, O.-B., Park, S., Cha, J. H., Kim, M.-H., Lee, Y., Kim, J.-H., Cho, K., & Kim, H.-S. (2016). Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer’s Disease. Scientific Reports. https://doi.org/10.1038/srep34433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.